Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effect and Cost Effectiveness of Ca Antagonist in Combination With AII Receptor Antagonist in Patient With Essential Hypertension (PMS Study)

NCT01518855 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01518855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01518855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effect and Cost Effectiveness of Ca Antagonist in Combination With AII Receptor Antagonist in Patient With Essential Hypertension (PMS Study)
Lead sponsor
Bayer
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2004
Completion date
April 30, 2005
Enrollment
514 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension